Hypofractionated Radiotherapy plus Cetuximab in Locally Advanced Head and Neck Cancer

被引：7
|
作者：
Teoh, D. C. [1 ]
Rodger, S. [2 ]
Say, J. [2 ]
Hartley, A. [1 ]
机构：
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Fac Med, Birmingham, W Midlands, England
来源：
CLINICAL ONCOLOGY | 2008年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.clon.2008.07.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：717 / 717
页数：1
相关论文
共 50 条
  • [1] Elderly patients concomitant radiotherapy plus cetuximab in locally advanced head and neck cancer
    Falk, A. T.
    Hebert, C.
    Paquet, M.
    Tran, A.
    Peyrade, F.
    Saada, E.
    Reure, J.
    Dassonville, O.
    Poissonnet, G.
    Bozec, A.
    Thariat, J.
    Leysalle, A.
    Chand, M. E.
    Benezery, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S521 - S521
  • [2] Radiotherapy combined with Cetuximab for locally advanced head and neck cancer
    Acevedo-Henao, C-M
    Valette, G.
    Marianowski, R.
    Pradier, O.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 96 - 96
  • [3] Cetuximab plus radiotherapy for head and neck cancer
    Cengiz, M
    Yildiz, F
    Genc, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (20): : 2187 - 2187
  • [4] Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck
    Griffin, S.
    Walker, S.
    Sculpher, M.
    White, S.
    Erhorn, S.
    Brent, S.
    Dyker, A.
    Ferrie, L.
    Gilfillan, C.
    Horsley, W.
    Macfarlane, K.
    Thomas, S.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [5] Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients
    Franzese, Ciro
    Fogliata, Antonella
    Franceschini, Davide
    Navarria, Pierina
    Cozzi, Luca
    Tomatis, Stefano
    De Virgilio, Armando
    Spriano, Giuseppe
    Scorsetti, Marta
    [J]. LARYNGOSCOPE, 2020, 130 (04): : E163 - E170
  • [6] Radiotherapy combined with cetuximab for locally advanced head and neck cancer: Results and toxicity
    Acevedo-Henao, C. M.
    Valette, G.
    Miglierini, P.
    Lefur, E.
    Pradier, O.
    [J]. CANCER RADIOTHERAPIE, 2012, 16 (07): : 601 - 603
  • [7] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    Francesca De Felice
    Luigia Vetrone
    Nadia Bulzonetti
    Rossella Caiazzo
    Francesco Marampon
    Daniela Musio
    Vincenzo Tombolini
    [J]. Medical Oncology, 2019, 36
  • [8] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    De Felice, Francesca
    Vetrone, Luigia
    Bulzonetti, Nadia
    Caiazzo, Rossella
    Marampon, Francesco
    Musio, Daniela
    Tombolini, Vincenzo
    [J]. MEDICAL ONCOLOGY, 2019, 36 (08)
  • [9] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
    Ferris, Robert L.
    Moskovitz, Jessica
    Kunning, Sheryl
    Ruffin, Ayana T.
    Reeder, Carly
    Ohr, James
    Gooding, William E.
    Kim, Seungwon
    Karlovits, Brian J.
    Vignali, Dario A. A.
    Duvvuri, Umamaheswar
    Johnson, Jonas T.
    Petro, Daniel
    Heron, Dwight E.
    Clump, David A.
    Bruno, Tullia C.
    Bauman, Julie E.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1335 - 1344
  • [10] Cetuximab, cisplatin and amifostine during accelerated radiotherapy for locally advanced head and neck cancer
    Tsoutsou, P. G.
    Danielidis, V.
    Koukourakis, M. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345